US Stock MarketDetailed Quotes
CVKD Cadrenal Therapeutics
- 0.450
- +0.020+4.53%
Trading Apr 29 15:02 ET
7.20MMarket Cap-700P/E (TTM)
0.470High0.420Low186.08KVolume0.430Open0.431Pre Close82.45KTurnover2.34%Turnover RatioLossP/E (Static)16.01MShares3.14052wk High0.94P/B3.59MFloat Cap0.36052wk Low--Dividend TTM7.97MShs Float6.750Historical High--Div YieldTTM11.61%Amplitude0.360Historical Low0.443Avg Price1Lot Size
Cadrenal Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -3.53M | -694.45K | -627.78K | -795.31K | -3,133.01%-1.41M | -43.7K |
| Net income from continuing operations | ---8.36M | ---1.14M | ---1.04M | ---1M | -2,828.75%-5.17M | ---176.65K |
| Operating gains losses | --956.23K | --0 | --0 | --0 | 62,073.86%956.23K | --1.54K |
| Depreciation and amortization | --1.98K | --597 | --597 | --596 | --190 | --0 |
| Other non cash items | --3.01M | --24 | --89 | --90 | 120,061.72%3.01M | --2.51K |
| Change In working capital | --144.31K | --345.88K | --254.92K | --39.21K | -484.55%-495.7K | --128.9K |
| -Change in prepaid assets | ---66.96K | --78.93K | --66.59K | --67.44K | -12,588.67%-279.91K | ---2.21K |
| -Change in payables and accrued expense | ---463.22K | --266.95K | --188.33K | ---28.23K | -773.40%-890.28K | --132.21K |
| -Change in other current assets | --2.2K | ---1 | --1 | ---1 | 300.18%2.2K | ---1.1K |
| -Change in other working capital | --672.3K | --0 | --0 | --0 | --672.3K | ---- |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | ---3.53M | ---694.45K | ---627.78K | ---795.31K | -3,133.01%-1.41M | ---43.7K |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -3.25K | 0 | -1 | |||
| Net PPE purchase and sale | ---3.25K | --0 | ---1 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ---3.25K | --0 | ---1 | ---- | ---- | ---- |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 11.9M | -12.5K | 6.51M | 0 | 968.80%5.41M | 506.04K |
| Net issuance payments of debt | ---250K | --0 | --0 | ---250K | --0 | --498.54K |
| Net common stock issuance | --11.9M | ---12.5K | --6.51M | --0 | 72,014.33%5.41M | --7.5K |
| Proceeds from stock option exercised by employees | --250K | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | --11.9M | ---12.5K | --6.51M | --0 | 968.80%5.41M | --506.04K |
| Net cash flow | ||||||
| Beginning cash position | --32.59K | --9.11M | --3.23M | --4.03M | --32.59K | --0 |
| Current changes in cash | --8.37M | ---706.95K | --5.88M | ---798.56K | 764.25%4M | --462.34K |
| End cash Position | --8.4M | --8.4M | --9.11M | --3.23M | 771.30%4.03M | --462.34K |
| Free cash flow | ---3.53M | ---694.45K | ---627.78K | ---798.56K | -3,133.01%-1.41M | ---43.7K |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg